Literature DB >> 11093121

T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection.

M K Maini1, S Reignat, C Boni, G S Ogg, A S King, F Malacarne, G J Webster, A Bertoletti.   

Abstract

T cells specific for a single viral epitope, but using different T cell receptors, should have flexibility in their epitope recognition to protect the infected host against the emergence of viral escape mutants. Therefore, polyclonality of the hepatitis B virus (HBV)-specific cytotoxic T lymphocyte response has been hypothesized to be a major determinant in the control of infection. We analyzed the Vbeta chain composition of the core 18-27-specific CD8 cells in acute and persistently HBV-infected patients using HLA-A2 tetrameric complexes and a panel of Vbeta antibodies. Different T cell receptors were utilized by core 18-27-specific CD8 cells both in patients with acute and chronic infection. The functional ability of these epitope-specific T cells to respond to potential viral mutations was then tested. The polyclonal HBV-specific CD8 response present in patients with acute hepatitis displayed a limited efficiency to recognize mutations introduced within the epitope. The ability of core 18-27-specific CD8 to tolerate epitope mutations was found only during persistent HBV infection. The data suggest that although a clonally heterogeneous CD8 response can be largely inhibited by the occurrence of single epitope mutations in primary HBV infection, preferential selection of T cells able to counteract the emergence of viral mutations can occur during persistent infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093121     DOI: 10.1002/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease.

Authors:  Christopher P Desmond; Silvana Gaudieri; Ian R James; Katja Pfafferott; Abha Chopra; George K Lau; Jennifer Audsley; Caroline Day; Sarah Chivers; Adam Gordon; Peter A Revill; Scott Bowden; Anna Ayres; Paul V Desmond; Alexander J Thompson; Stuart K Roberts; Stephen A Locarnini; Simon A Mallal; Sharon R Lewin
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Cross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.

Authors:  Virginie Prod'homme; Christelle Retière; Ralitza Valtcheva; Marc Bonneville; Marie-Martine Hallet
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 3.  Photochemical approaches to T-cell activation.

Authors:  Morgan Huse
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

Review 4.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection.

Authors:  Zhi-Tao Yang; Su-Yuan Huang; Li Chen; Feng Liu; Xiao-Hui Cai; Yang-Fan Guo; Ming-Jie Wang; Yue Han; De-Min Yu; Jie-Hong Jiang; Dong-Hua Zhang; Qi-Ming Gong; Guo-Qing Zhang; Guo-Qing Zang; Zhong-Hua Lu; Li-Hua Huang; Xin-Xin Zhang
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 6.  Hepatitis B infection: current concepts and future challenges.

Authors:  G Nebbia; D Peppa; M K Maini
Journal:  QJM       Date:  2012-02

7.  Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis.

Authors:  H Pilch; H Höhn; K Freitag; C Neukirch; A Necker; P Haddad; B Tanner; P G Knapstein; M J Maeurer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

8.  Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Authors:  H Höhn; C Neukirch; K Freitag; A Necker; W Hitzler; B Seliger; M J Maeurer
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.

Authors:  Jing You; Lin Zhuang; Yi-Feng Zhang; Hong-Ying Chen; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Teerha Piratvisuth; Edward McNeil; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

10.  A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.

Authors:  H-G Liu; Z-P Fan; W-W Chen; H-Y Yang; Q-F Liu; H Zhang; P Tien; F-S Wang
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.